Cyclopropylindole derivatives as selective serotonin reuptake inhibitors

   
   

The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulations comprising said compounds ##STR1## useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive-compulsive disorder, feeding disorders, premenstrual dysphoric disorder, panic disorders and psychotic disorders including bipolar disorder and schizophrenia.

A invenção atual relaciona-se aos compostos da fórmula (I) e pharmaceutically de sais ou de solvates aceitáveis disso e pharmaceutically os formulations aceitáveis que compreendem o ## dito do ## STR1 dos compostos útil para o tratamento do depression, dos disorders de ansiedade, da ejaculação prematura, da dor crônica, do disorder obsessive-obsessive-compulsive, de disorders de alimentação, do disorder dysphoric premenstrual, dos disorders do pânico e de disorders psychotic including o disorder bipolar e a esquizofrenia.

 
Web www.patentalert.com

< HMGI proteins in cancer and obesity

< Hydroxyphenstatin and the prodrugs thereof

> Inhibitors of farnesyl protein transferase

> Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways

~ 00126